AU2017277631B2 - Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA - Google Patents

Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA Download PDF

Info

Publication number
AU2017277631B2
AU2017277631B2 AU2017277631A AU2017277631A AU2017277631B2 AU 2017277631 B2 AU2017277631 B2 AU 2017277631B2 AU 2017277631 A AU2017277631 A AU 2017277631A AU 2017277631 A AU2017277631 A AU 2017277631A AU 2017277631 B2 AU2017277631 B2 AU 2017277631B2
Authority
AU
Australia
Prior art keywords
atps
phase
probe
polymer
phase solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017277631A
Other languages
English (en)
Other versions
AU2017277631A1 (en
Inventor
Daniel William BRADBURY
Shin Ting Sherine Frieda CHEUNG
Daniel Takashi KAMEI
Benjamin Ming WU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of AU2017277631A1 publication Critical patent/AU2017277631A1/en
Priority to AU2023282181A priority Critical patent/AU2023282181A1/en
Application granted granted Critical
Publication of AU2017277631B2 publication Critical patent/AU2017277631B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/625—Detection means characterised by use of a special device being a nucleic acid test strip device, e.g. dipsticks, strips, tapes, CD plates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/631—Detection means characterised by use of a special device being a biochannel or pore

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2017277631A 2016-06-09 2017-06-07 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA Active AU2017277631B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023282181A AU2023282181A1 (en) 2016-06-09 2023-12-11 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662348038P 2016-06-09 2016-06-09
US62/348,038 2016-06-09
PCT/US2017/036418 WO2017214315A1 (en) 2016-06-09 2017-06-07 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023282181A Division AU2023282181A1 (en) 2016-06-09 2023-12-11 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna

Publications (2)

Publication Number Publication Date
AU2017277631A1 AU2017277631A1 (en) 2019-01-24
AU2017277631B2 true AU2017277631B2 (en) 2024-01-25

Family

ID=60578148

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2017277631A Active AU2017277631B2 (en) 2016-06-09 2017-06-07 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA
AU2023282181A Pending AU2023282181A1 (en) 2016-06-09 2023-12-11 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023282181A Pending AU2023282181A1 (en) 2016-06-09 2023-12-11 Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna

Country Status (9)

Country Link
US (1) US11828755B2 (enExample)
EP (2) EP3469365B1 (enExample)
JP (1) JP7320951B2 (enExample)
KR (1) KR102592388B1 (enExample)
CN (2) CN109477133B (enExample)
AU (2) AU2017277631B2 (enExample)
ES (1) ES2939842T3 (enExample)
PL (1) PL3469365T3 (enExample)
WO (1) WO2017214315A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102749064B1 (ko) 2014-03-07 2024-12-31 더 리전트 오브 더 유니버시티 오브 캘리포니아 분석물 추출, 농축 및 검출을 통합하기 위한 장치
AU2016318103B2 (en) 2015-09-04 2022-11-17 The Regents Of The University Of California Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
WO2017214315A1 (en) 2016-06-09 2017-12-14 The Regents Of The University Of California Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna
WO2018039139A1 (en) 2016-08-22 2018-03-01 The Regents Of The University Of California Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
WO2018183211A1 (en) 2017-03-27 2018-10-04 The Regents Of The University Of California Semi-quantitative lateral-flow immunoassay for the detection of csf leaks
WO2018183454A1 (en) * 2017-03-28 2018-10-04 Chiu Yin To Method and device for accurate diagnosis of dental diseases
CN114839374A (zh) 2017-03-28 2022-08-02 相达生物科技国际有限公司 用于在液体活检中准确诊断疾病靶向生物标记的方法
WO2018222972A1 (en) 2017-06-01 2018-12-06 Yin To Chiu Phase separation behavior modifying agents for aqueous two-phase separation within porous material
US11609232B2 (en) 2017-09-01 2023-03-21 Phase Diagnostics, Inc. Method and device of using aqueous two-phase systems (ATPS) for enhancing diagnostics for sexually transmitted infections
ES2964100T3 (es) 2017-09-18 2024-04-04 Phase Scient International Ltd Método de utilización de un sistema acuoso bifásico para el aislamiento, purificación y/o concentración de fragmentos cortos de ácidos nucleicos
US12043826B2 (en) 2018-01-19 2024-07-23 Phase Scientific International, Ltd. Spontaneous nucleic acid purification and concentration in a single step
EP3740588A4 (en) 2018-01-19 2021-10-20 Phase Scientific International, Ltd. METHOD OF ISOLATION AND PURIFICATION OF NUCLEIC ACIDS USING A SOLID-LIQUID PHASE SYSTEM
CN108896506B (zh) * 2018-07-16 2020-10-27 济南大学 检测碱性磷酸酶活性以及碱性磷酸酶抑制剂浓度的方法
CN110205236A (zh) * 2019-06-12 2019-09-06 中国检验检疫科学研究院 一种基于rpa技术快速检测核酸的纸微流控芯片
BR112022018784A2 (pt) 2020-03-20 2023-01-31 Phase Scient International Ltd Composições e métodos para extração de ácido ribonucleico
CN111672544B (zh) * 2020-06-08 2022-03-01 江苏师范大学 一种基于水两相系统的纸基生化试剂存储方法
JPWO2022075313A1 (enExample) * 2020-10-06 2022-04-14
US12383906B2 (en) 2021-06-14 2025-08-12 University Of Washington Device and method for detection of pathogens
CN113528666B (zh) * 2021-07-16 2023-09-05 南京林业大学 一种多类型非编码rna检测方法及其在胃癌预警中的应用
CN113791214B (zh) * 2021-11-15 2022-02-22 南京黎明生物制品有限公司 一种沙眼衣原体抗原检测用增强液及其应用
WO2023147557A2 (en) * 2022-01-28 2023-08-03 The Johns Hopkins University Bio-engineered enzymes and uses thereof
US20230400459A1 (en) * 2022-06-09 2023-12-14 Hero Scientific Ltd. Gargle specimen sampling
CN115200954B (zh) * 2022-06-28 2025-05-06 珠海大略科技有限公司 一种降低唾液粘度的方法及其应用
NL2033124B1 (en) * 2022-09-23 2024-03-29 Rapidemic B V Methods and device for multiple-label nucleic acid amplification and detection
EP4612288A1 (en) 2022-11-02 2025-09-10 Phase Scientific International, Ltd. Methods for isolating target analytes from biological samples using atps and solid phase media

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011159537A2 (en) * 2010-06-15 2011-12-22 The Regents Of The University Of California Method and device for analyte detection
WO2015134938A1 (en) * 2014-03-07 2015-09-11 The Regents Of The University Of California Devices for integrating analyte extraction, concentration and detection

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
JPS6412935A (en) 1987-07-02 1989-01-17 Mitsubishi Electric Corp Constant-speed travel device for vehicle
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
CA2020029A1 (en) 1989-07-12 1991-01-13 Yatin B. Thakore Device and method for separation of plasma from blood and determination of blood analytes
US5141850A (en) 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5710005A (en) 1996-10-29 1998-01-20 Biocode, Inc. Analyte detection with a gradient lateral flow device
US6979576B1 (en) 1997-07-25 2005-12-27 Shu-Ching Cheng Methods of use of one step immunochromatographic device for Streptococcus A antigen
US6194221B1 (en) 1996-11-19 2001-02-27 Wyntek Diagnostics, Inc. Hybrid one-step immunochromatographic device and method of use
US6924153B1 (en) 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
EP1064553A4 (en) 1998-03-16 2001-09-12 Quidel Corp DEVICE AND METHOD FOR IMMUNOASSAY
US6743605B1 (en) 1998-06-24 2004-06-01 Enzo Life Sciences, Inc. Linear amplification of specific nucleic acid sequences
US7390675B2 (en) 1999-10-15 2008-06-24 Christopher Feistel Multi-functional and configurable assay
DK1340085T3 (da) 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en biologisk celle i en legemsvæskepröve
US6855561B2 (en) 2001-09-10 2005-02-15 Quidel Corporation Method for adding an apparent non-signal line to a lateral flow assay
US20030215358A1 (en) 2002-01-15 2003-11-20 Schulman Lloyd S. Liquid permeable composition in dry reagent devices
JP3797480B2 (ja) 2002-03-04 2006-07-19 株式会社東北テクノアーチ ネコ腎臓病診断マーカー
AU2003243559A1 (en) 2002-06-13 2003-12-31 Neuropro Technologies, Inc. Apparatus and methods for detecting cerebrospinal fluid
US7244394B2 (en) 2002-10-03 2007-07-17 Novartis Ag Methods and kits for assays of analytes of interest in tears
US7459314B2 (en) 2003-02-13 2008-12-02 Inverness Medical Switzerland Gmbh Lateral flow immunoassay controls
WO2004081528A2 (en) 2003-03-10 2004-09-23 Robinson Joseph R Assay device and method
US20040203079A1 (en) 2003-04-09 2004-10-14 Research Foundation Of The State University Of New York Methods and kits for detecting cerebrospinal fluid in a sample
US8003765B2 (en) 2003-04-09 2011-08-23 Stony Brook Anaesthesiology, University Faculty Practice Corporation Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
US20070003992A1 (en) 2003-04-09 2007-01-04 Pentyala Srinivas N Methods and kits for detecting cerebrospinal fluid in a sample
JPWO2005042579A1 (ja) 2003-10-31 2008-01-10 富士レビオ株式会社 抗ｓａｒｓウイルス抗体、該抗体を産生するハイブリドーマ及び該抗体を用いる免疫測定試薬
WO2005075998A1 (en) 2004-01-29 2005-08-18 Dsm Ip Assets B.V. Improved lateral flow binding assay
US7435577B2 (en) 2004-02-03 2008-10-14 Polymer Technology Systems, Inc. Direct measurement of chlolesterol from low density lipoprotein with test strip
WO2005098439A2 (en) 2004-03-30 2005-10-20 Whatman, Inc. Lateral flow format, materials and mehtods
EP1609800B1 (de) 2004-06-25 2007-11-14 Kühni Ag Verfahren zur Extraktion von biologischem Material
US20060019406A1 (en) 2004-07-23 2006-01-26 Ning Wei Lateral flow device for the detection of large pathogens
US8445293B2 (en) 2005-02-09 2013-05-21 Rapid Pathogen Screening, Inc. Method to increase specificity and/or accuracy of lateral flow immunoassays
US20060246513A1 (en) 2005-05-02 2006-11-02 Bohannon Robert C Method and device to detect the presence of analytes in a sample
WO2006122450A1 (en) 2005-05-20 2006-11-23 Calypte Biomedical Corporation Oral fluid rapid immunochromatography test
US7794656B2 (en) 2006-01-23 2010-09-14 Quidel Corporation Device for handling and analysis of a biological sample
WO2007092302A2 (en) 2006-02-07 2007-08-16 Envirologix Inc. Test device for analyte detection
WO2007098184A2 (en) 2006-02-21 2007-08-30 Nanogen, Inc. Methods and compositions for analyte detection
US20090110601A1 (en) 2006-07-09 2009-04-30 Raphael Levi Molecularly imprinted polymers for detection in lateral flow devices
WO2008043040A2 (en) 2006-10-05 2008-04-10 Massachusetts Institute Of Technology Integrated microfluidic device for preconcentration and detection of multiple biomarkers
CN101578520B (zh) 2006-10-18 2015-09-16 哈佛学院院长等 基于形成图案的多孔介质的横向流动和穿过生物测定装置、及其制备方法和使用方法
EP2076775B1 (en) 2006-10-18 2015-08-19 President and Fellows of Harvard College Lateral flow and flow-through bioassay based on patterned porous media, methods of making same, and methods of using same
US20080138842A1 (en) 2006-12-11 2008-06-12 Hans Boehringer Indirect lateral flow sandwich assay
KR100902093B1 (ko) 2007-05-23 2009-06-09 인하대학교 산학협력단 미세채널 내에서 가시광선의 투과도 측정을 이용한 액체의Ｄｒｏｐｌｅｔ／Ｐｌｕｇ 및 미세입자 크기와 개수측정장치 및 측정방법
WO2009018348A1 (en) 2007-07-30 2009-02-05 Cornell Research Foundation, Inc. Microchannel detection device and use thereof
WO2009083975A2 (en) 2007-12-27 2009-07-09 Infigo Diagnostics Ltd. Small molecules and protein analysis devices based on molecular imprinted polymers
US8628729B2 (en) 2008-03-27 2014-01-14 President And Fellows Of Harvard College Three-dimensional microfluidic devices
WO2009137059A1 (en) * 2008-05-05 2009-11-12 Los Alamos National Security, Llc Highly simplified lateral flow-based nucleic acid sample preparation and passive fluid flow control
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
WO2010027812A2 (en) 2008-08-25 2010-03-11 University Of Washington Microfluidic systems incorporating flow-through membranes
KR101761426B1 (ko) 2009-04-28 2017-07-25 덴카 세이켄 가부시키가이샤 간이 멤브레인 어세이 장치
CA2807645C (en) 2009-08-07 2021-09-07 Affinimark Technologies, Inc. Device and methods for the immunological identification of cerebrospinal fluid
JP5205354B2 (ja) 2009-09-30 2013-06-05 富士フイルム株式会社 クロマトグラフ測定装置
US9244057B2 (en) 2010-03-18 2016-01-26 The Regents Of The University Of Michigan Multiphase microarrays and uses thereof
US20110312759A1 (en) 2010-06-17 2011-12-22 Geneasys Pty Ltd Genetic analysis loc with reagent reservoir
FR2963108B1 (fr) 2010-07-21 2017-06-23 Diagast Procede magnetique d'immunodiagnostic et kit pour la mise en evidence de complexe anticorps/antigene de groupe/phenotype sanguin
WO2012125781A2 (en) 2011-03-15 2012-09-20 Colorado State University Research Foundation Rapid detection of pathogens using paper devices
DE102011001743A1 (de) 2011-04-01 2012-10-04 Technische Universität Dortmund Verfahren zur Trennung/Reinigung von Biomolekühlen
US9493736B2 (en) * 2011-04-27 2016-11-15 Merck Patent Gmbh Method for lysing cells
US9939442B2 (en) 2011-09-08 2018-04-10 The Regents Of The University Of California Salivary biomarkers for gastric cancer detection
CN104040358A (zh) 2011-09-30 2014-09-10 加利福尼亚大学董事会 微流体装置和使用其测定流体样品的方法
DK2788478T3 (en) 2011-12-09 2017-10-09 Pasteur Institut Multiplex IMMUNSCREENINGSASSAY
WO2013105090A1 (en) 2012-01-11 2013-07-18 Aptateck Bio Ltd. A versatile lateral flow strip device
JP5917201B2 (ja) 2012-03-02 2016-05-11 田中貴金属工業株式会社 イムノクロマトグラフィー用試験ストリップ
US20140004539A1 (en) 2012-06-15 2014-01-02 The Regents Of The University Of Michigan Systems and methods for multiplex solution assays
US9310300B2 (en) 2012-08-03 2016-04-12 Ingeneron Incorporated Compact portable apparatus for optical assay
US20160282343A1 (en) 2012-08-15 2016-09-29 Immunolab LLC Quantitative lateral flow assay strips for quantitative analysis of an analyte, kits containing such strips and methods of manufacture and use of same
US20150017656A1 (en) 2012-11-15 2015-01-15 Daniel Wang Rapid Lateral Flow Assay Method for Detecting Low Quantity Liquid or Dry Samples
US20150198592A1 (en) 2012-11-15 2015-07-16 Daniel Wang Rapid Lateral Flow Assay Method for Low Quantity Liquid or Dry Samples
US20150329900A1 (en) * 2012-12-18 2015-11-19 Qiagen Gmbh Nucleic Acid Amplification Method
CN103808926B (zh) 2014-01-14 2016-08-17 中国科学院生物物理研究所 纳米模拟酶免疫层析检测方法
US20160313307A1 (en) 2015-04-23 2016-10-27 Ted Titmus Diagnostic test strip for oral samples and method of use therefore
AU2016318103B2 (en) 2015-09-04 2022-11-17 The Regents Of The University Of California Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
US20170323441A1 (en) 2016-05-09 2017-11-09 University Of Washington Filter-free devices and systems for measuring fluorescence of a microfluidic assay and associated methods of use
WO2017214315A1 (en) 2016-06-09 2017-12-14 The Regents Of The University Of California Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna
US11761958B2 (en) 2016-07-12 2023-09-19 Purdue Research Foundation Devices, systems, and methods for the detection of a target analyte using magnetic focus lateral flow immunoassay techniques
WO2018039139A1 (en) 2016-08-22 2018-03-01 The Regents Of The University Of California Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
WO2018183211A1 (en) 2017-03-27 2018-10-04 The Regents Of The University Of California Semi-quantitative lateral-flow immunoassay for the detection of csf leaks
EP3635400A4 (en) 2017-05-31 2021-02-24 The Regents of The University of California SINGLE-LEVEL, ATPS-EXTENDED LFA DIAGNOSTIC DESIGN

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011159537A2 (en) * 2010-06-15 2011-12-22 The Regents Of The University Of California Method and device for analyte detection
WO2015134938A1 (en) * 2014-03-07 2015-09-11 The Regents Of The University Of California Devices for integrating analyte extraction, concentration and detection

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHIU, R. Y. T. ET AL.: "An aqueous two-phase system for the concentration and extraction of proteins from the interface for detection using the lateral-flow immunoassay", PLOS ONE, vol. 10, no. 11, 10 November 2015, pages 1 - 14 *
FOAD M. ET AL: "Concentration of mammalian genomic DNA using two-phase aqueous micellar systems", BIOTECHNOLOGY AND BIOENGINEERING, vol. 102, no. 6, 15 April 2009, pages 1613 - 1623 *
FOAD M. ET AL: "Enhancing the lateral-flow immunoassay for viral detection using an aqueous two-phase micellar system", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, vol. 398, no. 7 - 8, (2010-09-24), pages 2955 - 2961 *
RIBEIRO S C ET AL: "Isolation of plasmid DNA from cell lysates by aqueous two-phase systems", BIOTECHNOLOGY AND BIOENGINEERING, JOHN WILEY, HOBOKEN, USA, vol. 78, no. 4, (2002-03-15), pages 376 - 384, XP071153131 *

Also Published As

Publication number Publication date
EP4202439C0 (en) 2025-02-19
CN109477133A (zh) 2019-03-15
US11828755B2 (en) 2023-11-28
EP3469365B1 (en) 2022-12-07
ES2939842T3 (es) 2023-04-27
AU2023282181A1 (en) 2024-01-18
CN109477133B (zh) 2023-04-11
WO2017214315A1 (en) 2017-12-14
EP3469365A4 (en) 2020-01-08
EP4202439B1 (en) 2025-02-19
JP2019525136A (ja) 2019-09-05
PL3469365T3 (pl) 2023-04-03
KR20190006597A (ko) 2019-01-18
AU2017277631A1 (en) 2019-01-24
EP4202439A1 (en) 2023-06-28
CN116083539A (zh) 2023-05-09
KR102592388B1 (ko) 2023-10-20
US20190250156A1 (en) 2019-08-15
JP7320951B2 (ja) 2023-08-04
EP3469365A1 (en) 2019-04-17

Similar Documents

Publication Publication Date Title
AU2017277631B2 (en) Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA
US11885803B2 (en) Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
US20200150116A1 (en) Single-step atps enhanced lfa diagnostic design
US11327075B2 (en) Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
JP4266634B2 (ja) リガンド検出方法
AU2015226930A1 (en) Devices for integrating analyte extraction, concentration and detection
WO2004092342A2 (en) Lateral flow system for nucleic acid detection
HK40089486A (zh) 纯化和扩增核酸的方法
HK1262844A1 (en) Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna
HK1262844B (en) Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying dna
EP1933141B1 (en) Antigen detection method involving an oligonucleotide enhanced collodial gold signal
HK40071485B (zh) 用於多孔材料中双水相分离的相分离行为改性剂

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)